3 Healthcare & Biotech Stocks up over xx% past 10 days
Powered by HealthTechMovers.com
Today, the screeners at HealthTechMovers.com picked up 3 Healthcare & Biotech Stocks up over XX% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com. Another great tool for charting is TradingView.com, so you might want to check that out too.
Mountain Crest Acquisition II, BTTX
Summary: Better Therapeutics Inc. is a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases. Better Therapeutics Inc., formerly known as Mountain Crest Acquisition Corp II, is based in SAN FRANCISCO.
Recent Price (approx 10:00am EST.): $$1.86
Previous Close: $1.8300
Percentage Price Change Past 10 Days: +106.14%
TipRanks.com reports that Mountain Crest Acquisition II currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $16.50.
Click here to get the full story >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Nuvectis Pharma Inc. is a biopharmaceutical company. It focused on the development of innovative precision medicines for serious conditions of unmet medical need in oncology. Nuvectis Pharma Inc. is based in Fort Lee, NJ.
Recent Price (approx 10:00am EST.): $$18.33
Previous Close: $17.86
Percentage Price Change Past 10 Days: +91.58%
TipRanks.com reports that Nuvectis Pharma currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $21.00.
Click here to get the full story >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Compass Therapeutics Inc. is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematologic malignancies. The company's lead product candidate includes CTX-471. Compass Therapeutics Inc. is based in Boston, MA.
Recent Price (approx 10:00am EST.): $$2.49
Previous Close: $2.3000
Percentage Price Change Past 10 Days: +14.19%
TipRanks.com reports that Compass Therapeutics currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $9.75.
Click here to get the full story >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com. The other great tool for charting is TradingView.com, so you might want to check that out too.
